ADC Therapeutics SA
NYSE:ADCT
3.1 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 17.41 | 18.053 | 16.79 | 14.493 | 19.283 | 18.992 | 69.798 | 76.321 | 17.291 | 46.498 | 17.01 | 13.147 | 3.76 | 0 | 51.9 | 0 | 0 | 0 | 0 | 0 | 1.962 | 1.17 | 0.258 | 0.258 | 0.313 | 0.313 |
| Cost of Revenue
| 2.055 | 3.353 | 1.215 | 0.366 | 1.319 | 0.59 | 0.489 | 1.295 | 2.266 | 0.529 | 0.77 | 0.502 | 0.121 | 0.578 | 25.95 | 32.155 | 25.95 | 35.375 | 30.424 | 30.541 | 21.76 | 23.286 | 29.09 | 29.09 | 29.953 | 29.953 |
| Gross Profit
| 15.355 | 14.7 | 15.575 | 14.127 | 17.964 | 18.402 | 69.309 | 75.026 | 15.025 | 45.969 | 16.24 | 12.645 | 3.639 | -0.578 | 25.95 | -32.155 | -25.95 | -35.375 | -30.424 | -30.541 | -19.798 | -22.116 | -28.833 | -28.833 | -29.641 | -29.641 |
| Gross Profit Ratio
| 0.882 | 0.814 | 0.928 | 0.975 | 0.932 | 0.969 | 0.993 | 0.983 | 0.869 | 0.989 | 0.955 | 0.962 | 0.968 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | -10.091 | -18.903 | -111.971 | -111.971 | -94.85 | -94.85 |
| Reseach & Development Expenses
| 24.295 | 25.735 | 30.331 | 28.44 | 31.944 | 39.48 | 48.733 | 41.676 | 48.537 | 48.952 | 42.492 | 36.805 | 39.533 | 39.172 | 48.552 | 32.155 | 25.95 | 35.375 | 30.424 | 30.541 | 21.76 | 23.286 | 29.09 | 29.09 | 30.067 | 30.067 |
| General & Administrative Expenses
| 16.089 | 17.609 | 17.212 | 15.056 | 12.599 | 15.143 | 15.138 | 36.464 | 35.899 | 19.011 | 17.926 | 33.632 | 19.367 | 17.582 | 20.096 | 20.273 | 18.999 | 5.882 | 4.92 | 2.302 | 4.089 | 3.296 | 2.45 | 2.45 | 1.935 | 1.935 |
| Selling & Marketing Expenses
| 4.85 | 5.812 | 9.282 | 8.035 | 8.329 | 15.351 | 16.176 | 8.236 | 9.259 | 18.37 | 18.603 | 17.045 | 15.221 | 13.911 | 9.353 | 6.116 | 4.004 | 2.628 | 0 | 0 | 0 | 0 | -0.05 | -0.05 | 0.05 | 0.05 |
| SG&A
| 20.101 | 22.578 | 25.222 | 23.091 | 12.599 | 30.494 | 31.314 | 36.464 | 35.899 | 37.381 | 36.529 | 33.632 | 34.588 | 31.493 | 29.449 | 20.273 | 18.999 | 8.51 | 4.92 | 2.302 | 4.089 | 3.296 | 2.4 | 2.4 | 1.985 | 1.985 |
| Other Expenses
| 2.23 | 0.263 | 3.777 | 0.683 | 0.296 | 1.412 | -1.275 | 11.838 | 0.114 | 0.008 | 15.929 | -7.146 | 2.104 | 21.363 | 0.143 | 34.013 | -80.702 | 0.148 | 0.222 | 1.433 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 44.396 | 48.313 | 55.553 | 51.531 | 57.753 | 69.974 | 80.047 | 78.14 | 84.436 | 86.333 | 79.021 | 70.437 | 74.121 | 70.665 | 78.001 | 52.428 | 44.949 | 43.885 | 35.732 | 32.843 | 25.849 | 3.33 | 2.371 | 2.371 | 2.02 | 2.02 |
| Operating Income
| -29.041 | -33.613 | -39.978 | -37.404 | -39.789 | -51.572 | -10.738 | 6.867 | -69.411 | -40.364 | -62.781 | -57.792 | -70.482 | -70.665 | -78.001 | -52.428 | -44.949 | -43.885 | -35.732 | -32.843 | -23.887 | -25.412 | -31.232 | -31.232 | -31.625 | -31.625 |
| Operating Income Ratio
| -1.668 | -1.862 | -2.381 | -2.581 | -2.063 | -2.715 | -0.154 | 0.09 | -4.014 | -0.868 | -3.691 | -4.396 | -18.745 | 0 | -1.503 | 0 | 0 | 0 | 0 | 0 | -12.175 | -21.72 | -121.289 | -121.289 | -101.2 | -101.2 |
| Total Other Income Expenses Net
| -6.992 | -12.39 | 0.106 | -0.687 | -0.453 | -8.116 | -9.452 | -58.186 | 4.09 | 22.533 | 15.929 | -9.363 | 0.693 | 21.23 | 24.145 | 33.874 | -80.802 | 0.177 | 0.395 | 1.073 | 0.01 | 0.583 | 0.636 | 0.636 | 0.785 | 0.785 |
| Income Before Tax
| -36.033 | -46.003 | -39.872 | -47.893 | -53.727 | -59.688 | -20.19 | -51.319 | -65.321 | -17.831 | -56.352 | -71.404 | -72.329 | -51.42 | -55.803 | -20.331 | -126.453 | -43.376 | -35.17 | -31.073 | -23.254 | -24.83 | -30.596 | -30.596 | -30.84 | -30.84 |
| Income Before Tax Ratio
| -2.07 | -2.548 | -2.375 | -3.305 | -2.786 | -3.143 | -0.289 | -0.672 | -3.778 | -0.383 | -3.313 | -5.431 | -19.236 | 0 | -1.075 | 0 | 0 | 0 | 0 | 0 | -11.852 | -21.222 | -118.819 | -118.819 | -98.688 | -98.688 |
| Income Tax Expense
| -0.086 | -0.084 | 43.171 | -0.086 | -6.61 | -0.262 | 3.967 | -0.711 | -0.947 | -1.17 | -21.971 | 0.145 | 0.24 | 0.107 | 0.126 | -0.003 | 0.104 | 0.1 | 0.115 | 0.268 | 0.094 | 0.1 | 0.038 | 0.038 | 0.074 | 0.074 |
| Net Income
| -36.544 | -46.606 | -85.031 | -47.807 | -47.117 | -59.426 | -24.157 | -50.608 | -64.374 | -16.661 | -34.381 | -71.549 | -72.569 | -51.527 | -55.929 | -20.328 | -126.557 | -43.476 | -35.285 | -31.341 | -23.348 | -24.929 | -30.634 | -30.634 | -30.914 | -30.914 |
| Net Income Ratio
| -2.099 | -2.582 | -5.064 | -3.299 | -2.443 | -3.129 | -0.346 | -0.663 | -3.723 | -0.358 | -2.021 | -5.442 | -19.3 | 0 | -1.078 | 0 | 0 | 0 | 0 | 0 | -11.9 | -21.307 | -118.967 | -118.967 | -98.925 | -98.925 |
| EPS
| -0.38 | -0.56 | -1.03 | -0.58 | -0.58 | -0.74 | -0.3 | -0.65 | -0.84 | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 | -0.73 | -0.29 | -2.01 | -0.68 | -0.48 | -0.43 | -0.32 | -0.53 | -3.08 | -0.569 | -0.574 | -0.574 |
| EPS Diluted
| -0.38 | -0.56 | -1.03 | -0.58 | -0.58 | -0.74 | -0.3 | -0.65 | -0.84 | -0.22 | -0.45 | -0.93 | -0.95 | -0.67 | -0.73 | -0.29 | -2.01 | -0.68 | -0.48 | -0.43 | -0.32 | -0.53 | -3.08 | -0.569 | -0.574 | -0.574 |
| EBITDA
| -28.203 | -32.77 | -25.368 | -34.197 | -37.119 | -48.525 | -10.386 | 7.439 | -70.612 | -23.956 | -46.832 | -66.474 | -68.897 | -49.236 | -53.39 | -17.763 | -125.019 | -42.92 | -34.795 | -30.327 | -23.228 | -25.278 | -30.848 | -31.1 | -31.513 | -31.513 |
| EBITDA Ratio
| -1.62 | -1.815 | -1.511 | -2.36 | -1.925 | -2.555 | -0.149 | 0.097 | -4.084 | -0.515 | -2.753 | -5.056 | -18.324 | 0 | -1.029 | 0 | 0 | 0 | 0 | 0 | -11.839 | -21.605 | -119.798 | -120.777 | -100.842 | -100.842 |